{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:54:16Z","timestamp":1791863656315,"version":"4.3.4"},"reference-count":267,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"am","delay-in-days":277,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"US Government National Institutes of Health","doi-asserted-by":"publisher","award":["R01ES033345"],"award-info":[{"award-number":["R01ES033345"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"US Government National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL134779"],"award-info":[{"award-number":["R01HL134779"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.reprotox.2024.108702","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T21:30:14Z","timestamp":1725139814000},"page":"108702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Per- and polyfluoroalkyl substances (PFAS) and hypertensive disorders of Pregnancy- integration of epidemiological and mechanistic evidence"],"prefix":"10.1016","volume":"130","author":[{"given":"Sri Vidya","family":"Dangudubiyyam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.reprotox.2024.108702_bib1","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.jacc.2020.03.028","article-title":"Incidence and long-term outcomes of hypertensive disorders of pregnancy","volume":"75","author":"Garovic","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.reprotox.2024.108702_bib2","first-page":"1122","article-title":"Hypertension in pregnancy, Report of the American College of Obstetricians and Gynecologists\u2019 task force on hypertension in pregnancy.","volume":"122","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.reprotox.2024.108702_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.preghy.2020.12.002","article-title":"Medical expenditures for hypertensive disorders during pregnancy that resulted in a live birth among privately insured women","volume":"23","author":"Li","year":"2021","journal-title":"Pregnancy Hypertens."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib4","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","article-title":"Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association","volume":"79","author":"Garovic","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.reprotox.2024.108702_bib5","series-title":"Pathology of the Human Placenta","first-page":"380","article-title":"Anatomy and pathology of the umbilical cord","author":"Benirschke","year":"2006"},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ajog.2012.01.022","article-title":"Doppler assessment of the fetus with intrauterine growth restriction","volume":"206","author":"Berkley","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.reprotox.2024.108702_bib7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00281-016-0579-8","article-title":"Preeclampsia and health risks later in life: an immunological link","volume":"38","author":"Cheng","year":"2016","journal-title":"Semin. Immunopathol."},{"issue":"5","key":"10.1016\/j.reprotox.2024.108702_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/children10050826","article-title":"Short- and Long-Term Outcomes of Preeclampsia in Offspring: review of the Literature","volume":"10","author":"Koulouraki","year":"2023","journal-title":"Children"},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/M17-2740","article-title":"Hypertensive disorders of pregnancy and maternal cardiovascular disease risk factor development: an observational Cohort Study","volume":"169","author":"Stuart","year":"2018","journal-title":"Ann. Intern Med."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10654-013-9762-6","article-title":"Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis","volume":"28","author":"Brown","year":"2013","journal-title":"Eur. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003497","article-title":"Preeclampsia and future cardiovascular health: a systematic review and meta-analysis","volume":"10","author":"Wu","year":"2017","journal-title":"Circ. Cardiovasc Qual. Outcomes"},{"issue":"17","key":"10.1016\/j.reprotox.2024.108702_bib12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.15585\/mmwr.mm7117a1","article-title":"Hypertensive disorders in pregnancy and mortality at delivery hospitalization - United States, 2017-2019","volume":"71","author":"Ford","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12884-021-03809-2","article-title":"Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"issue":"Pt 2","key":"10.1016\/j.reprotox.2024.108702_bib14","article-title":"Perfluoroalkyl and polyfluoroalkyl substances and hypertensive disorders of pregnancy: a systematic review and meta-analysis","volume":"231","author":"Hu","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.reprotox.2024.108702_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.111113","article-title":"Considering environmental exposures to per- and polyfluoroalkyl substances (PFAS) as risk factors for hypertensive disorders of pregnancy","volume":"197","author":"Erinc","year":"2021","journal-title":"Environ. Res."},{"key":"10.1016\/j.reprotox.2024.108702_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152565","article-title":"Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: a review including the placenta as a target tissue and possible driver of peri- and postnatal effects","volume":"443","author":"Blake","year":"2020","journal-title":"Toxicology"},{"issue":"47","key":"10.1016\/j.reprotox.2024.108702_bib17","doi-asserted-by":"crossref","first-page":"67053","DOI":"10.1007\/s11356-021-15061-4","article-title":"The relationship between maternal perfluoroalkylated substances exposure and low birth weight of offspring: a systematic review and meta-analysis","volume":"28","author":"Cao","year":"2021","journal-title":"Environ. Sci. Pollut. Res. Int."},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/aje\/kwx332","article-title":"Early-pregnancy plasma concentrations of perfluoroalkyl substances and birth outcomes in project viva: confounded by pregnancy hemodynamics?","volume":"187","author":"Sagiv","year":"2018","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.reprotox.2024.108702_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.scitotenv.2017.06.273","article-title":"The impact of prenatal perfluoroalkyl substances exposure on neonatal and child growth","volume":"607-608","author":"Chen","year":"2017","journal-title":"Sci. Total Environ."},{"issue":"6","key":"10.1016\/j.reprotox.2024.108702_bib20","doi-asserted-by":"crossref","DOI":"10.1289\/EHP641","article-title":"Perfluoroalkyl substances during pregnancy and offspring weight and adiposity at birth: examining mediation by maternal fasting glucose in the healthy start study","volume":"125","author":"Starling","year":"2017","journal-title":"Environ. Health Perspect."},{"issue":"10","key":"10.1016\/j.reprotox.2024.108702_bib21","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1289\/ehp.1003096","article-title":"Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls","volume":"120","author":"Maisonet","year":"2012","journal-title":"Environ. Health Perspect."},{"issue":"8","key":"10.1016\/j.reprotox.2024.108702_bib22","article-title":"Perfluorinated compounds in umbilical cord blood and adverse birth outcomes","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.reprotox.2024.108702_bib23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1289\/ehp.1104034","article-title":"Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study","volume":"120","author":"Halldorsson","year":"2012","journal-title":"Environ. Health Perspect."},{"issue":"11","key":"10.1016\/j.reprotox.2024.108702_bib24","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/aje\/kwq289","article-title":"Prenatal exposures to perfluorinated chemicals and anthropometric measures in infancy","volume":"172","author":"Andersen","year":"2010","journal-title":"Am. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib25","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1289\/ehp.11681","article-title":"Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth","volume":"117","author":"Washino","year":"2009","journal-title":"Environ. Health Perspect."},{"issue":"11","key":"10.1016\/j.reprotox.2024.108702_bib26","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1289\/ehp.10334","article-title":"Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth","volume":"115","author":"Apelberg","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.reprotox.2024.108702_bib27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.envint.2019.01.010","article-title":"Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies","volume":"124","author":"Mamsen","year":"2019","journal-title":"Environ. Int."},{"issue":"11","key":"10.1016\/j.reprotox.2024.108702_bib28","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1021\/acs.est.6b06049","article-title":"Chlorinated polyfluoroalkyl ether sulfonic acids in matched maternal, cord, and placenta samples: a study of transplacental transfer","volume":"51","author":"Chen","year":"2017","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.reprotox.2024.108702_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.scitotenv.2017.04.058","article-title":"Concentration of perfluorinated compounds and cotinine in human foetal organs, placenta, and maternal plasma","volume":"596-597","author":"Mamsen","year":"2017","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.reprotox.2024.108702_bib30","doi-asserted-by":"crossref","first-page":"21699","DOI":"10.1038\/srep21699","article-title":"Placental transfer of perfluoroalkyl substances and associations with thyroid hormones: Beijing prenatal exposure study","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.reprotox.2024.108702_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.envint.2015.07.014","article-title":"Perfluoroalkyl acid (PFAA) levels and profiles in breast milk, maternal and cord serum of French women and their newborns","volume":"84","author":"Cariou","year":"2015","journal-title":"Environ. Int."},{"issue":"16","key":"10.1016\/j.reprotox.2024.108702_bib32","doi-asserted-by":"crossref","first-page":"9600","DOI":"10.1021\/es501811k","article-title":"Changes in serum concentrations of maternal poly- and perfluoroalkyl substances over the course of pregnancy and predictors of exposure in a multiethnic cohort of Cincinnati, Ohio pregnant women during 2003-2006","volume":"48","author":"Kato","year":"2014","journal-title":"Environ. Sci. Technol."},{"issue":"14","key":"10.1016\/j.reprotox.2024.108702_bib33","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.1021\/es400937y","article-title":"Distribution of poly- and perfluoroalkyl substances in matched samples from pregnant women and carbon chain length related maternal transfer","volume":"47","author":"Zhang","year":"2013","journal-title":"Environ. Sci. Technol."},{"issue":"5","key":"10.1016\/j.reprotox.2024.108702_bib34","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.chemosphere.2012.08.035","article-title":"Concentrations of perfluoroalkyl compounds in maternal and umbilical cord sera and birth outcomes in Korea","volume":"90","author":"Lee","year":"2013","journal-title":"Chemosphere"},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijheh.2011.08.011","article-title":"Placental transfer of perfluorinated compounds is selective--a Norwegian mother and child sub-cohort study","volume":"215","author":"Gutzkow","year":"2012","journal-title":"Int. J. Hyg. Environ. Health"},{"issue":"11","key":"10.1016\/j.reprotox.2024.108702_bib36","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1289\/ehp.1003265","article-title":"Isomer profiles of perfluorochemicals in matched maternal, cord, and house dust samples: manufacturing sources and transplacental transfer","volume":"119","author":"Beesoon","year":"2011","journal-title":"Environ. Health Perspect."},{"issue":"18","key":"10.1016\/j.reprotox.2024.108702_bib37","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1021\/es101184f","article-title":"Pre- and postnatal exposure to perfluorinated compounds (PFCs)","volume":"44","author":"Fromme","year":"2010","journal-title":"Environ. Sci. Technol."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.envres.2008.06.001","article-title":"Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples","volume":"108","author":"Monroy","year":"2008","journal-title":"Environ. Res."},{"issue":"11","key":"10.1016\/j.reprotox.2024.108702_bib39","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1289\/ehp.10506","article-title":"Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort","volume":"115","author":"Fei","year":"2007","journal-title":"Environ. Health Perspect."},{"issue":"7","key":"10.1016\/j.reprotox.2024.108702_bib40","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00420-006-0165-9","article-title":"Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study","volume":"80","author":"Midasch","year":"2007","journal-title":"Int. Arch. Occup. Environ. Health"},{"issue":"11","key":"10.1016\/j.reprotox.2024.108702_bib41","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1289\/ehp.6864","article-title":"Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy","volume":"112","author":"Inoue","year":"2004","journal-title":"Environ. Health Perspect."},{"issue":"12","key":"10.1016\/j.reprotox.2024.108702_bib42","volume":"16","author":"Chain","year":"2018","journal-title":"Risk Hum. Health Relat. Presence Perfluorooctane Sulfonic Acid. Perfluorooctanoic Acid. Food EFSA J."},{"key":"10.1016\/j.reprotox.2024.108702_bib43","unstructured":"EPA, 2021, Health Effects Support Document for Perfluorooctane Sulfonate (PFOS)EPA 822-R-16-002 WashingtonDC: U.S. EPAAccessed April 08\u3008https:\/\/www.epa.gov\/sites\/production\/files\/2016-05\/documents\/pfos_hesd_final_508.pdf\u3009.."},{"key":"10.1016\/j.reprotox.2024.108702_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.110740","article-title":"Exposure to perfluoroalkyl substances (PFAS) and dyslipidemia, hypertension and obesity in adolescents. The Fit Futures study","volume":"195","author":"Averina","year":"2021","journal-title":"Environ. Res."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib45","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12940-020-00656-0","article-title":"Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults","volume":"19","author":"Pitter","year":"2020","journal-title":"Environ. Health"},{"key":"10.1016\/j.reprotox.2024.108702_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.112903","article-title":"Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - a longitudinal study over 10 years","volume":"211","author":"Dunder","year":"2022","journal-title":"Environ. Res."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12940-020-00588-9","article-title":"Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water","volume":"19","author":"Li","year":"2020","journal-title":"Environ. Health"},{"key":"10.1016\/j.reprotox.2024.108702_bib48","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.envint.2019.05.027","article-title":"Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study","volume":"129","author":"Lin","year":"2019","journal-title":"Environ. Int."},{"key":"10.1016\/j.reprotox.2024.108702_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2022.107179","article-title":"Per- and perfluoroalkyl substances alternatives, mixtures and liver function in adults: a community-based population study in China","volume":"163","author":"Liu","year":"2022","journal-title":"Environ. Int."},{"key":"10.1016\/j.reprotox.2024.108702_bib50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.envint.2018.04.052","article-title":"Changes in markers of liver function in relation to changes in perfluoroalkyl substances - a longitudinal study","volume":"117","author":"Salihovic","year":"2018","journal-title":"Environ. Int."},{"issue":"6","key":"10.1016\/j.reprotox.2024.108702_bib51","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/10962247.2021.1909668","article-title":"Critical review on PFOA, kidney cancer, and testicular cancer","volume":"71","author":"Bartell","year":"2021","journal-title":"J. Air Waste Manag Assoc."},{"issue":"7","key":"10.1016\/j.reprotox.2024.108702_bib52","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1021\/acs.est.1c08669","article-title":"Global exposure to Per- and Polyfluoroalkyl substances and associated burden of low birthweight","volume":"56","author":"Fan","year":"2022","journal-title":"Environ. Sci. Technol."},{"issue":"6","key":"10.1016\/j.reprotox.2024.108702_bib53","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41390-019-0720-1","article-title":"Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight","volume":"87","author":"Wikstrom","year":"2020","journal-title":"Pediatr. Res."},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/1547691X.2012.755580","article-title":"Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood","volume":"10","author":"Granum","year":"2013","journal-title":"J. Immunotoxicol."},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib55","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jama.2011.2034","article-title":"Serum vaccine antibody concentrations in children exposed to perfluorinated compounds","volume":"307","author":"Grandjean","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.reprotox.2024.108702_bib56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-069X-14-2","article-title":"Pregnancy serum concentrations of perfluorinated alkyl substances and offspring behaviour and motor development at age 5-9 years--a prospective study","volume":"14","author":"Hoyer","year":"2015","journal-title":"Environ. Health"},{"issue":"12","key":"10.1016\/j.reprotox.2024.108702_bib57","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1289\/ehp.1001898","article-title":"Exposure to polyfluoroalkyl chemicals and attention deficit\/hyperactivity disorder in U.S. children 12-15 years of age","volume":"118","author":"Hoffman","year":"2010","journal-title":"Environ. Health Perspect."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib58","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1289\/EHP246","article-title":"Prenatal exposure to Perfluoroalkyl substances and adiposity in early and mid-childhood","volume":"125","author":"Mora","year":"2017","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib59","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/oby.21258","article-title":"Prenatal perfluoroalkyl substance exposure and child adiposity at 8 years of age: The HOME study","volume":"24","author":"Braun","year":"2016","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib60","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12884-020-2765-x","article-title":"Associations between hydration state and pregnancy complications, maternal-infant outcomes: protocol of a prospective observational cohort study","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib61","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13321-017-0247-6","article-title":"The CompTox chemistry dashboard: a community data resource for environmental chemistry","volume":"9","author":"Williams","year":"2017","journal-title":"J. Chemin."},{"issue":"23","key":"10.1016\/j.reprotox.2024.108702_bib62","doi-asserted-by":"crossref","first-page":"15575","DOI":"10.1021\/acs.est.1c06896","article-title":"A new OECD definition for per- and polyfluoroalkyl substances","volume":"55","author":"Wang","year":"2021","journal-title":"Environ. Sci. Technol."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11783-009-0022-7","article-title":"Treatment technologies for aqueous perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA)","volume":"3","author":"Vecitis","year":"2009","journal-title":"Front. Environ. Sci. Eng. China"},{"key":"10.1016\/j.reprotox.2024.108702_bib64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.scitotenv.2015.04.023","article-title":"Review on the occurrence, fate and removal of perfluorinated compounds during wastewater treatment","volume":"524-525","author":"Arvaniti","year":"2015","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.reprotox.2024.108702_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2019.136485","article-title":"Risk assessment of PFASs in drinking water using a probabilistic risk quotient methodology","volume":"712","author":"Thomaidi","year":"2020","journal-title":"Sci. Total Environ."},{"issue":"6","key":"10.1016\/j.reprotox.2024.108702_bib66","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1021\/acs.estlett.8b00266","article-title":"PFOA and PFOS are generated from zwitterionic and cationic precursor compounds during water disinfection with chlorine or ozone","volume":"5","author":"Xiao","year":"2018","journal-title":"Environ. Sci. Technol. Lett."},{"key":"10.1016\/j.reprotox.2024.108702_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/ieam.4414","article-title":"The impact of precursors on aquatic exposure assessment for PFAS: insights from bioaccumulation modeling","author":"Glaser","year":"2021","journal-title":"Integr. Environ. Assess. Manag"},{"issue":"18","key":"10.1016\/j.reprotox.2024.108702_bib68","doi-asserted-by":"crossref","first-page":"9923","DOI":"10.1021\/acs.est.6b00140","article-title":"Generation of perfluoroalkyl acids from aerobic biotransformation of quaternary ammonium Polyfluoroalkyl surfactants","volume":"50","author":"Mejia-Avenda\u00f1o","year":"2016","journal-title":"Environ. Sci. Technol."},{"issue":"20","key":"10.1016\/j.reprotox.2024.108702_bib69","doi-asserted-by":"crossref","first-page":"11818","DOI":"10.1021\/acs.est.9b05379","article-title":"Sorption and desorption mechanisms of cationic and zwitterionic Per- and Polyfluoroalkyl substances in natural soils: thermodynamics and hysteresis","volume":"53","author":"Xiao","year":"2019","journal-title":"Environ. Sci. Technol."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib70","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1021\/acs.est.9b05102","article-title":"Bioaccumulation of zwitterionic polyfluoroalkyl substances in earthworms exposed to aqueous film-forming foam impacted soils","volume":"54","author":"Munoz","year":"2020","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.reprotox.2024.108702_bib71","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.envint.2014.11.013","article-title":"Hazard assessment of fluorinated alternatives to long-chain perfluoroalkyl acids (PFAAs) and their precursors: status quo, ongoing challenges and possible solutions","volume":"75","author":"Wang","year":"2015","journal-title":"Environ. Int."},{"key":"10.1016\/j.reprotox.2024.108702_bib72","first-page":"99","article-title":"Environmental and toxicity effects of perfluoroalkylated substances","volume":"179","author":"Hekster","year":"2003","journal-title":"Rev. Environ. Contam. Toxicol."},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib73","first-page":"326","article-title":"Analytical chemistry of perfluoroalkylated substances. TrAC Trends in","volume":"25","author":"Voogt","year":"2006","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib74","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1039\/C0EM00373E","article-title":"Polyfluoroalkyl compounds in the aquatic environment: a review of their occurrence and fate","volume":"13","author":"Ahrens","year":"2011","journal-title":"J. Environ. Monit."},{"issue":"12","key":"10.1016\/j.reprotox.2024.108702_bib75","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1039\/D0EM00291G","article-title":"An overview of the uses of per- and polyfluoroalkyl substances (PFAS)","volume":"22","author":"Gl\u00fcge","year":"2020","journal-title":"Environ. Sci. Process Impacts"},{"issue":"5","key":"10.1016\/j.reprotox.2024.108702_bib76","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1021\/acs.est.6b04806","article-title":"A never-ending story of per- and polyfluoroalkyl substances (PFASs)?","volume":"51","author":"Wang","year":"2017","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.reprotox.2024.108702_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.127900","article-title":"Assessment of PFAS fate, transport, and treatment inhibition associated with a simulated AFFF release within a wastewater treatment plant","volume":"262","author":"Gonzalez","year":"2021","journal-title":"Chemosphere"},{"key":"10.1016\/j.reprotox.2024.108702_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.140017","article-title":"PFAS concentrations in soils: background levels versus contaminated sites","volume":"740","author":"Brusseau","year":"2020","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.reprotox.2024.108702_bib79","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.scitotenv.2012.10.091","article-title":"Transport of perfluoroalkyl substances (PFAS) from an arctic glacier to downstream locations: implications for sources","volume":"447","author":"Kwok","year":"2013","journal-title":"Sci. Total Environ."},{"issue":"8","key":"10.1016\/j.reprotox.2024.108702_bib80","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.chemosphere.2009.11.038","article-title":"Distribution of perfluoroalkyl compounds in seawater from northern Europe, Atlantic Ocean, and Southern Ocean","volume":"78","author":"Ahrens","year":"2010","journal-title":"Chemosphere"},{"issue":"7","key":"10.1016\/j.reprotox.2024.108702_bib81","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1021\/es001834k","article-title":"Global distribution of perfluorooctane sulfonate in wildlife","volume":"35","author":"Giesy","year":"2001","journal-title":"Environ. Sci. Technol."},{"issue":"14","key":"10.1016\/j.reprotox.2024.108702_bib82","doi-asserted-by":"crossref","first-page":"9601","DOI":"10.1021\/acs.est.1c01645","article-title":"Investigating the uptake and fate of Poly- and Perfluoroalkylated Substances (PFAS) in sea ice using an experimental sea ice chamber","volume":"55","author":"Garnett","year":"2021","journal-title":"Environ. Sci. Technol."},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib83","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ieam.258","article-title":"Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins","volume":"7","author":"Buck","year":"2011","journal-title":"Integr. Environ. Assess. Manag"},{"issue":"12","key":"10.1016\/j.reprotox.2024.108702_bib84","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1039\/D1EM00329A","article-title":"Surface-water\/groundwater boundaries affect seasonal PFAS concentrations and PFAA precursor transformations","volume":"23","author":"Tokranov","year":"2021","journal-title":"Environ. Sci. Process Impacts"},{"key":"10.1016\/j.reprotox.2024.108702_bib85","unstructured":"Evans, S., PFAS Contamination of Drinking Water Far More Prevalent Than Previously Reported. Viewed on 09.03.2020. https:\/\/www.ewg.org\/research\/national-pfas-testing\/. 2020: https:\/\/www.ewg.org\/research\/national-pfas-testing\/."},{"key":"10.1016\/j.reprotox.2024.108702_bib86","unstructured":"EWG. PFAS contamination tracker. 2022 [cited 2022 June 8]; Available from: https:\/\/www.ewg.org\/interactive-maps\/pfas_contamination\/."},{"issue":"12","key":"10.1016\/j.reprotox.2024.108702_bib87","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad142","article-title":"Legacy and emerging Perfluoroalkyl and Polyfluoroalkyl substances regulate steroidogenesis in the male Gonad","volume":"164","author":"Daugherty","year":"2023","journal-title":"Endocrinology"},{"issue":"42","key":"10.1016\/j.reprotox.2024.108702_bib88","doi-asserted-by":"crossref","first-page":"15782","DOI":"10.1021\/acs.est.2c06715","article-title":"Elevated levels of ultrashort- and short-chain perfluoroalkyl acids in US homes and people","volume":"57","author":"Zheng","year":"2023","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.reprotox.2024.108702_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.127659","article-title":"Disposal of products and materials containing per- and polyfluoroalkyl substances (PFAS): a cyclical problem","volume":"260","author":"Stoiber","year":"2020","journal-title":"Chemosphere"},{"key":"10.1016\/j.reprotox.2024.108702_bib90","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.chemosphere.2016.06.109","article-title":"A North American and global survey of perfluoroalkyl substances in surface soils: distribution patterns and mode of occurrence","volume":"161","author":"Rankin","year":"2016","journal-title":"Chemosphere"},{"issue":"10","key":"10.1016\/j.reprotox.2024.108702_bib91","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1021\/acs.estlett.6b00260","article-title":"Detection of Poly- and Perfluoroalkyl Substances (PFASs) in U.S. drinking water linked to industrial sites, military fire training areas, and wastewater treatment plants","volume":"3","author":"Hu","year":"2016","journal-title":"Environ. Sci. Technol. Lett."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib92","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41370-018-0094-1","article-title":"A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects","volume":"29","author":"Sunderland","year":"2019","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"10.1016\/j.reprotox.2024.108702_bib93","author":"EPA","year":"2021","journal-title":"Address Chall. PFAS: Prot. Groundw. Treat. Contam. Sources"},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib94","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s13280-016-0848-8","article-title":"A review of contamination of surface-, ground-, and drinking water in Sweden by perfluoroalkyl and polyfluoroalkyl substances (PFASs)","volume":"46","author":"Banzhaf","year":"2017","journal-title":"Ambio"},{"key":"10.1016\/j.reprotox.2024.108702_bib95","author":"EPA","year":"2023","journal-title":"Per- Polyfluoroalkyl Subst. (PFAS)Propos. PFAS Natl. Prim. Drink. Water Regul."},{"key":"10.1016\/j.reprotox.2024.108702_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.108033","article-title":"Per- and polyfluoroalkyl substances (PFAS) in United States tapwater: comparison of underserved private-well and public-supply exposures and associated health implications","volume":"178","author":"Smalling","year":"2023","journal-title":"Environ. Int."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib97","doi-asserted-by":"crossref","first-page":"25002","DOI":"10.1289\/EHP10359","article-title":"Current breast Milk PFAS levels in the United States and Canada: after all this time, why don't we know more?","volume":"130","author":"LaKind","year":"2022","journal-title":"Environ. Health Perspect."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib98","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1021\/acs.est.5b03806","article-title":"Ubiquitous occurrence of fluorotelomer alcohols in eco-friendly paper-made food-contact materials and their implication for human exposure","volume":"50","author":"Yuan","year":"2016","journal-title":"Environ. Sci. Technol."},{"issue":"10","key":"10.1016\/j.reprotox.2024.108702_bib99","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/02652030500183474","article-title":"Perfluorochemicals: potential sources of and migration from food packaging","volume":"22","author":"Begley","year":"2005","journal-title":"Food Addit. Contam."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib100","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/02652030701513784","article-title":"Migration of fluorochemical paper additives from food-contact paper into foods and food simulants","volume":"25","author":"Begley","year":"2008","journal-title":"Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess."},{"issue":"6","key":"10.1016\/j.reprotox.2024.108702_bib101","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.chemosphere.2009.04.044","article-title":"Fish consumption as a source of human exposure to perfluorinated alkyl substances in Sweden - analysis of edible fish from Lake V\u00e4ttern and the Baltic Sea","volume":"76","author":"Berger","year":"2009","journal-title":"Chemosphere"},{"key":"10.1016\/j.reprotox.2024.108702_bib102","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.scitotenv.2014.07.126","article-title":"Perfluorinated compounds in fish from U.S. urban rivers and the Great Lakes","volume":"499","author":"Stahl","year":"2014","journal-title":"Sci. Total Environ."},{"issue":"16","key":"10.1016\/j.reprotox.2024.108702_bib103","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1021\/jf800827r","article-title":"Cooking decreases observed perfluorinated compound concentrations in fish","volume":"56","author":"Del Gobbo","year":"2008","journal-title":"J. Agric. Food Chem."},{"issue":"12","key":"10.1016\/j.reprotox.2024.108702_bib104","article-title":"Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food","volume":"16","author":"Knutsen","year":"2018","journal-title":"EFSA J."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1021\/acs.jafc.6b04683","article-title":"Per- and Polyfluoroalkyl Substances (PFASs) in food and human dietary intake: a review of the recent scientific literature","volume":"65","author":"Domingo","year":"2017","journal-title":"J. Agric. Food Chem."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib106","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1539-6924.2008.01017.x","article-title":"Estimating consumer exposure to PFOS and PFOA","volume":"28","author":"Trudel","year":"2008","journal-title":"Risk Anal."},{"key":"10.1016\/j.reprotox.2024.108702_bib107","unstructured":"CDC, National Report on Human Exposure to Environmental Chemicals. 2019."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib108","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/oemed-2017-104651","article-title":"Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water","volume":"75","author":"Li","year":"2018","journal-title":"Occup. Environ. Med."},{"issue":"7","key":"10.1016\/j.reprotox.2024.108702_bib109","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1007\/s11356-014-3725-7","article-title":"PFOS and PFOA in paired urine and blood from general adults and pregnant women: assessment of urinary elimination","volume":"22","author":"Zhang","year":"2015","journal-title":"Environ. Sci. Pollut. Res. Int."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib110","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.reprotox.2012.05.039","article-title":"Comparison of polyfluoroalkyl compound concentrations in maternal serum and amniotic fluid: a pilot study","volume":"34","author":"Stein","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2024.108702_bib111","author":"ATSDR","year":"2024","journal-title":"PFAS Blood Test."},{"issue":"10","key":"10.1016\/j.reprotox.2024.108702_bib112","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1021\/acs.est.7b00268","article-title":"Isomer-specific transplacental transfer of Perfluoroalkyl Acids: results from a survey of paired maternal, cord sera, and placentas","volume":"51","author":"Chen","year":"2017","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.reprotox.2024.108702_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105789","article-title":"Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study","volume":"141","author":"Borghese","year":"2020","journal-title":"Environ. Int."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib114","doi-asserted-by":"crossref","first-page":"9179","DOI":"10.1038\/s41598-019-45483-7","article-title":"Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women","volume":"9","author":"Wikstrom","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.reprotox.2024.108702_bib115","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/aje\/kwt432","article-title":"Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study","volume":"179","author":"Starling","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.reprotox.2024.108702_bib116","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.envint.2013.10.004","article-title":"Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian mother and child cohort study","volume":"62","author":"Starling","year":"2014","journal-title":"Environ. Int."},{"issue":"10","key":"10.1016\/j.reprotox.2024.108702_bib117","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1289\/ehp.1206372","article-title":"Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the Mid-Ohio Valley, 2005-2010","volume":"121","author":"Darrow","year":"2013","journal-title":"Environ. Health Perspect."},{"issue":"7","key":"10.1016\/j.reprotox.2024.108702_bib118","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/aje\/kwp212","article-title":"Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome","volume":"170","author":"Stein","year":"2009","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib119","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12940-018-0445-3","article-title":"Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and the risk of hypertensive disorders of pregnancy","volume":"18","author":"Huang","year":"2019","journal-title":"Environ. Health"},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2605.2008.00870.x","article-title":"Emerging endocrine disrupters: perfluoroalkylated substances","volume":"31","author":"Jensen","year":"2008","journal-title":"Int. J. Androl."},{"issue":"5","key":"10.1016\/j.reprotox.2024.108702_bib121","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1021\/es020955c","article-title":"Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals","volume":"37","author":"Olsen","year":"2003","journal-title":"Environ. Sci. Technol."},{"issue":"7","key":"10.1016\/j.reprotox.2024.108702_bib122","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1021\/es4057467","article-title":"Highly elevated serum concentrations of perfluoroalkyl substances in fishery employees from Tangxun lake, china","volume":"48","author":"Zhou","year":"2014","journal-title":"Environ. Sci. Technol."},{"issue":"7","key":"10.1016\/j.reprotox.2024.108702_bib123","doi-asserted-by":"crossref","first-page":"146A","DOI":"10.1021\/es022253t","article-title":"Perfluorochemical surfactants in the environment","volume":"36","author":"Giesy","year":"2002","journal-title":"Environ. Sci. Technol."},{"issue":"3-04","key":"10.1016\/j.reprotox.2024.108702_bib124","first-page":"177","article-title":"Developmental origins of health and disease: the history of the barker hypothesis and assisted reproductive technology","volume":"36","author":"Carpinello","year":"2018","journal-title":"Semin Reprod. Med."},{"key":"10.1016\/j.reprotox.2024.108702_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2019.135885","article-title":"High trans-placental transfer of perfluoroalkyl substances alternatives in the matched maternal-cord blood serum: evidence from a birth cohort study","volume":"705","author":"Cai","year":"2020","journal-title":"Sci. Total Environ."},{"issue":"8","key":"10.1016\/j.reprotox.2024.108702_bib126","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1021\/acs.est.0c00829","article-title":"Transplacental transfer of per- and polyfluoroalkyl substances (PFASs): differences between preterm and full-term deliveries and associations with placental transporter mRNA expression","volume":"54","author":"Li","year":"2020","journal-title":"Environ. Sci. Technol."},{"issue":"13","key":"10.1016\/j.reprotox.2024.108702_bib127","doi-asserted-by":"crossref","first-page":"8158","DOI":"10.1021\/acs.est.9b07102","article-title":"Identifying risk factors for levels of Per- and Polyfluoroalkyl Substances (PFAS) in the placenta in a high-risk pregnancy cohort in North Carolina","volume":"54","author":"Bangma","year":"2020","journal-title":"Environ. Sci. Technol."},{"issue":"7","key":"10.1016\/j.reprotox.2024.108702_bib128","doi-asserted-by":"crossref","first-page":"77003","DOI":"10.1289\/EHP11546","article-title":"Extending nontargeted discovery of environmental chemical exposures during pregnancy and their association with pregnancy complications-a cross-sectional study","volume":"131","author":"Trowbridge","year":"2023","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.reprotox.2024.108702_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2019.05.024","article-title":"First-trimester maternal concentrations of polyfluoroalkyl substances and fetal growth throughout pregnancy","volume":"130","author":"Costa","year":"2019","journal-title":"Environ. Int."},{"issue":"11","key":"10.1016\/j.reprotox.2024.108702_bib130","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1021\/acs.est.9b00715","article-title":"Prenatal exposure to Per- and Polyfluoroalkyl Substances (PFASs) and association between the placental transfer efficiencies and dissociation constant of serum proteins-PFAS complexes","volume":"53","author":"Gao","year":"2019","journal-title":"Environ. Sci. Technol."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib131","doi-asserted-by":"crossref","first-page":"131","DOI":"10.26502\/jesph.96120193","article-title":"Elevated maternal testosterone levels alter PFOA elimination and tissue distribution in pregnant rats","volume":"7","author":"Yadav","year":"2023","journal-title":"J. Environ. Sci. Public Health"},{"issue":"10","key":"10.1016\/j.reprotox.2024.108702_bib132","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3109\/09513590.2012.683061","article-title":"A comparison of serum androgens in pre-eclamptic and normotensive pregnant women during the third trimester of pregnancy","volume":"28","author":"Sharifzadeh","year":"2012","journal-title":"Gynecol. Endocrinol."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib133","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1028-4559(09)60301-6","article-title":"Expression of androgen receptor in human placentas from normal and preeclamptic pregnancies","volume":"48","author":"Hsu","year":"2009","journal-title":"Taiwan J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.reprotox.2024.108702_bib134","first-page":"390","article-title":"The relationship between serum concentration of free testosterone and pre-eclampsia","volume":"59","author":"Ghorashi","year":"2008","journal-title":"Endokrynol. Pol."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib135","first-page":"228","article-title":"[High plasmatic androgen levels in women affected with pregnancy-induced hypertension]","volume":"58","author":"Gerulewicz-Vannini","year":"2006","journal-title":"Rev. Invest Clin."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib136","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejogrb.2005.07.007","article-title":"Androgen levels in the third trimester of pregnancy in patients with preeclampsia","volume":"126","author":"Salamalekis","year":"2006","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib137","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.0001-6349.2005.00493.x","article-title":"Early second-trimester maternal hyperandrogenemia and subsequent preeclampsia: a prospective study","volume":"84","author":"Carlsen","year":"2005","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"5","key":"10.1016\/j.reprotox.2024.108702_bib138","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.0001-6349.2004.00276.x","article-title":"The relationship between plasma levels of leptin and androgen in healthy and preeclamptic pregnant women","volume":"83","author":"Atamer","year":"2004","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib139","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0020-7292(03)00318-7","article-title":"Androgen levels in pre-eclamptic pregnant women","volume":"84","author":"Baksu","year":"2004","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib140","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ije\/dyg094","article-title":"Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies","volume":"32","author":"Troisi","year":"2003","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib141","first-page":"225","article-title":"Serum androgen markers in preeclampsia","volume":"48","author":"Miller","year":"2003","journal-title":"J. Reprod. Med."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib142","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/0144361031000074637","article-title":"The role of androgens in the aetiology and pathology of pre-eclampsia","volume":"23","author":"Ficicioglu","year":"2003","journal-title":"J. Obstet. Gynaecol."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib143","first-page":"552","article-title":"Human chorionic gonadotropin and testosterone in normal and preeclamptic pregnancies in relation to fetal sex","volume":"100","author":"Steier","year":"2002","journal-title":"Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.reprotox.2024.108702_bib144","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1034\/j.1600-0412.2001.801107.x","article-title":"Androgen levels of preeclamptic patients in the third trimester of pregnancy and six weeks after delivery","volume":"80","author":"Serin","year":"2001","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"1 Pt 1","key":"10.1016\/j.reprotox.2024.108702_bib145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0002-9378(99)70150-X","article-title":"Androgens in preeclampsia","volume":"180","author":"Acromite","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib146","first-page":"H231","article-title":"Distribution of cardiac output in ovine pregnancy","volume":"232","author":"Rosenfeld","year":"1977","journal-title":"Am. J. Physiol."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib147","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ccl.2012.05.004","article-title":"Physiologic changes during normal pregnancy and delivery","volume":"30","author":"Ouzounian","year":"2012","journal-title":"Cardiol. Clin."},{"issue":"6","key":"10.1016\/j.reprotox.2024.108702_bib148","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/hrt.68.12.540","article-title":"Adaptation of the maternal heart in pregnancy","volume":"68","author":"Hunter","year":"1992","journal-title":"Br. Heart J."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib149","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5830\/CVJA-2016-021","article-title":"Physiological changes in pregnancy","volume":"27","author":"Soma-Pillay","year":"2016","journal-title":"Cardiovasc J. Afr."},{"issue":"12","key":"10.1016\/j.reprotox.2024.108702_bib150","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/CIRCULATIONAHA.114.009029","article-title":"Cardiovascular physiology of pregnancy","volume":"130","author":"Sanghavi","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib151","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/JOE-16-0340","article-title":"Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia","volume":"232","author":"Boeldt","year":"2017","journal-title":"J. Endocrinol."},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib152","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1530\/REP-21-0428","article-title":"The role of angiotensin II and relaxin in vascular adaptation to pregnancy","volume":"164","author":"Doan","year":"2022","journal-title":"Reproduction"},{"issue":"5","key":"10.1016\/j.reprotox.2024.108702_bib153","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/biolre\/ioy130","article-title":"Pregnancy upregulates angiotensin type 2 receptor expression and increases blood flow in uterine arteries of rats","volume":"99","author":"Mishra","year":"2018","journal-title":"Biol. Reprod."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib154","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/biolre\/ioab051","article-title":"Activation of angiotensin type 2 receptor attenuates testosterone-induced hypertension and uterine vascular resistance in pregnant rats\u00a0\u2020","volume":"105","author":"Mishra","year":"2021","journal-title":"Biol. Reprod."},{"issue":"5","key":"10.1016\/j.reprotox.2024.108702_bib155","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/S0002-9378(11)90799-6","article-title":"Ontogeny of angiotensin II vascular smooth muscle receptors in ovine fetal aorta and placental and uterine arteries","volume":"168","author":"Rosenfeld","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib156","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1538-7836.2008.03259.x","article-title":"Vascular biology of preeclampsia","volume":"7","author":"Myatt","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"18","key":"10.1016\/j.reprotox.2024.108702_bib157","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1007\/s00018-019-03104-6","article-title":"Human placenta and trophoblast development: key molecular mechanisms and model systems","volume":"76","author":"Kn\u00f6fler","year":"2019","journal-title":"Cell Mol. Life Sci."},{"issue":"10","key":"10.1016\/j.reprotox.2024.108702_bib158","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1007\/s43032-020-00212-8","article-title":"Regulation of Uterine Spiral Artery Remodeling: a Review","volume":"27","author":"Albrecht","year":"2020","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.reprotox.2024.108702_bib159","series-title":"Vascular Biology of the Placenta. Chapter 4, Cell Types of the Placenta Vascular Biology of the Placenta","author":"Wang","year":"2010"},{"issue":"2S","key":"10.1016\/j.reprotox.2024.108702_bib160","doi-asserted-by":"crossref","first-page":"S895","DOI":"10.1016\/j.ajog.2020.09.026","article-title":"Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia","volume":"226","author":"Staff","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.reprotox.2024.108702_bib161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jri.2019.07.004","article-title":"The two-stage placental model of preeclampsia: an update","volume":"134-135","author":"Staff","year":"2019","journal-title":"J. Reprod. Immunol."},{"issue":"9","key":"10.1016\/j.reprotox.2024.108702_bib162","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm1452","article-title":"Decidual NK cells regulate key developmental processes at the human fetal-maternal interface","volume":"12","author":"Hanna","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.reprotox.2024.108702_bib163","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fimmu.2019.00478","article-title":"Therapeutic potential of regulatory T Cells in Preeclampsia-Opportunities and Challenges","volume":"10","author":"Robertson","year":"2019","journal-title":"Front. Immunol."},{"issue":"20","key":"10.1016\/j.reprotox.2024.108702_bib164","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011202","article-title":"Defective uteroplacental vascular remodeling in preeclampsia: key molecular factors leading to long term cardiovascular disease","volume":"22","author":"Hong","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/micc.12093","article-title":"Regulation of placental angiogenesis","volume":"21","author":"Chen","year":"2014","journal-title":"Microcirculation"},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib166","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267826","article-title":"AT2R activation increases in vitro angiogenesis in pregnant human uterine artery endothelial cells","volume":"17","author":"Mishra","year":"2022","journal-title":"PLoS One"},{"issue":"Suppl A","key":"10.1016\/j.reprotox.2024.108702_bib167","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1053\/plac.1999.0524","article-title":"Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review","volume":"21","author":"Ahmed","year":"2000","journal-title":"Placenta"},{"issue":"12","key":"10.1016\/j.reprotox.2024.108702_bib168","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/1947601911423031","article-title":"Vascular Endothelial Growth Factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies","volume":"2","author":"Shibuya","year":"2011","journal-title":"Genes Cancer"},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib169","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2023.5292","article-title":"Predictive value of the sFlt\u20111\/PlGF ratio in women with suspected preeclampsia: an update (Review)","volume":"52","author":"Velegrakis","year":"2023","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib170","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0002-9440(10)62567-9","article-title":"Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome","volume":"160","author":"Zhou","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.reprotox.2024.108702_bib171","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1681\/ASN.2009010061","article-title":"The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD","volume":"20","author":"Di Marco","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.reprotox.2024.108702_bib172","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.reprotox.2024.108702_bib173","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126815","article-title":"Circulating angiogenic factors and the risk of adverse outcomes among Haitian women with preeclampsia","volume":"10","author":"March","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib174","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124684","article-title":"First-trimester maternal serum levels of sFLT1, PGF and ADMA predict preeclampsia","volume":"10","author":"Bian","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.reprotox.2024.108702_bib175","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.reprotox.2024.108702_bib176","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.reprotox.2024.108702_bib177","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fphys.2016.00152","article-title":"Sex steroids modulate uterine-placental vasculature: implications for obstetrics and neonatal outcomes","volume":"7","author":"Maliqueo","year":"2016","journal-title":"Front. Physiol."},{"issue":"30","key":"10.1016\/j.reprotox.2024.108702_bib178","doi-asserted-by":"crossref","first-page":"12542","DOI":"10.1073\/pnas.0901647106","article-title":"De novo synthesis of estrogen in pregnant uterus is critical for stromal decidualization and angiogenesis","volume":"106","author":"Das","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.reprotox.2024.108702_bib179","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21114092","article-title":"Endometrial decidualization: the primary driver of pregnancy health","volume":"21","author":"Ng","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0306-3623(02)00129-5","article-title":"Estrogen and vascular function","volume":"38","author":"White","year":"2002","journal-title":"Vasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.reprotox.2024.108702_bib181","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.steroids.2013.01.003","article-title":"Protective actions of progesterone in the cardiovascular system: potential role of membrane progesterone receptors (mPRs) in mediating rapid effects","volume":"78","author":"Thomas","year":"2013","journal-title":"Steroids"},{"issue":"9","key":"10.1016\/j.reprotox.2024.108702_bib182","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1172\/JCI119022","article-title":"Nitric oxide contributes to estrogen-induced vasodilation of the ovine uterine circulation","volume":"98","author":"Rosenfeld","year":"1996","journal-title":"J. Clin. Invest"},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib183","doi-asserted-by":"crossref","first-page":"H1699","DOI":"10.1152\/ajpheart.2001.280.4.H1699","article-title":"Endothelial vasodilator production by uterine and systemic arteries. VII. Estrogen and progesterone effects on eNOS","volume":"280","author":"Rupnow","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"Suppl 3","key":"10.1016\/j.reprotox.2024.108702_bib184","first-page":"S189","article-title":"Physiological Changes in Pregnancy","volume":"25","author":"Gangakhedkar","year":"2021","journal-title":"Indian J. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.reprotox.2024.108702_bib185","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/oxfordjournals.humrep.a137595","article-title":"Immunohistochemical localization of androgen receptor in the human endometrium, decidua, placenta and pathological conditions of the endometrium","volume":"7","author":"Horie","year":"1992","journal-title":"Hum. Reprod."},{"issue":"5","key":"10.1016\/j.reprotox.2024.108702_bib186","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/jp.2011.101","article-title":"Fetal sex-related dysregulation in testosterone production and their receptor expression in the human placenta with preeclampsia","volume":"32","author":"Sathishkumar","year":"2012","journal-title":"J. Perinatol."},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib187","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1095\/biolreprod.114.118968","article-title":"Gestational exposure to elevated testosterone levels induces hypertension via heightened vascular angiotensin II type 1 receptor signaling in rats","volume":"91","author":"Chinnathambi","year":"2014","journal-title":"Biol. Reprod."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib188","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/HYPERTENSIONAHA.111.00486","article-title":"Testosterone alters maternal vascular adaptations: role of the endothelial NO system","volume":"61","author":"Chinnathambi","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.reprotox.2024.108702_bib189","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2016.05.014","article-title":"Maternal testosterone and placental function: effect of electroacupuncture on placental expression of angiogenic markers and fetal growth","volume":"433","author":"Fornes","year":"2016","journal-title":"Mol. Cell Endocrinol."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib190","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/HYPERTENSIONAHA.114.03283","article-title":"Elevated testosterone levels during rat pregnancy cause hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in uterine arteries","volume":"64","author":"Chinnathambi","year":"2014","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib191","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/HYPERTENSIONAHA.115.06946","article-title":"Elevated testosterone reduces uterine blood flow, spiral artery elongation, and placental oxygenation in pregnant rats","volume":"67","author":"Gopalakrishnan","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.reprotox.2024.108702_bib192","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1477-7827-9-110","article-title":"Prenatal testosterone-induced fetal growth restriction is associated with down-regulation of rat placental amino acid transport","volume":"9","author":"Sathishkumar","year":"2011","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib193","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/biolre\/ioac059","article-title":"Hyperandrogenism diminishes maternal-fetal fatty acid transport by increasing FABP4-mediated placental lipid accumulation","volume":"107","author":"Gopalakrishnan","year":"2022","journal-title":"Dagger Biol. Reprod."},{"issue":"11","key":"10.1016\/j.reprotox.2024.108702_bib194","doi-asserted-by":"crossref","first-page":"E1373","DOI":"10.1152\/ajpendo.00421.2012","article-title":"Maternal androgen excess reduces placental and fetal weights, increases placental steroidogenesis, and leads to long-term health effects in their female offspring","volume":"303","author":"Sun","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.reprotox.2024.108702_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.111632","article-title":"Per- and polyfluoroalkyl substances exposure during pregnancy and adverse pregnancy and birth outcomes: a systematic review and meta-analysis","volume":"201","author":"Gao","year":"2021","journal-title":"Environ. Res."},{"key":"10.1016\/j.reprotox.2024.108702_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.116017","article-title":"Association between prenatal perfluorinated compounds exposure and risk of pregnancy complications: a meta-analysis","volume":"272","author":"Pang","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"5","key":"10.1016\/j.reprotox.2024.108702_bib197","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00204-023-03477-5","article-title":"A review of cardiovascular effects and underlying mechanisms of legacy and emerging per- and polyfluoroalkyl substances (PFAS)","volume":"97","author":"Wen","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.reprotox.2024.108702_bib198","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.envres.2016.08.019","article-title":"Impacts of geocoding uncertainty on reconstructed PFOA exposures and their epidemiological association with preeclampsia","volume":"151","author":"Avanasi","year":"2016","journal-title":"Environ. Res."},{"key":"10.1016\/j.reprotox.2024.108702_bib199","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.envres.2016.01.011","article-title":"Variability and epistemic uncertainty in water ingestion rates and pharmacokinetic parameters, and impact on the association between perfluorooctanoate and preeclampsia in the C8 Health Project population","volume":"146","author":"Avanasi","year":"2016","journal-title":"Environ. Res."},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib200","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/EDE.0b013e31824cb93b","article-title":"Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community","volume":"23","author":"Savitz","year":"2012","journal-title":"Epidemiology"},{"key":"10.1016\/j.reprotox.2024.108702_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.112892","article-title":"Retrospective exposure reconstruction using approximate Bayesian computation: a case study on perfluorooctanoic acid and preeclampsia","volume":"209","author":"Zhu","year":"2022","journal-title":"Environ. Res."},{"key":"10.1016\/j.reprotox.2024.108702_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2022.137490","article-title":"In utero exposure to per-\/polyfluoroalkyl substances (PFASs): preeclampsia in pregnancy and low birth weight for neonates","volume":"313","author":"Tian","year":"2023","journal-title":"Chemosphere"},{"issue":"19","key":"10.1016\/j.reprotox.2024.108702_bib203","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20196886","article-title":"Relative risks of adverse perinatal outcomes in three Australian communities exposed to per- and Polyfluoroalkyl substances: data linkage study","volume":"20","author":"Law","year":"2023","journal-title":"Int J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib204","doi-asserted-by":"crossref","DOI":"10.1097\/EE9.0000000000000209","article-title":"Per- and polyfluoroalkyl substances in drinking water and hypertensive disorders of pregnancy in the United States during 2013-2015","volume":"6","author":"Zhu","year":"2022","journal-title":"Environ. Epidemiol."},{"issue":"Pt 2","key":"10.1016\/j.reprotox.2024.108702_bib205","article-title":"Associations of perfluoroalkyl and polyfluoroalkyl substances with gestational hypertension and blood pressure during pregnancy: a cohort study","volume":"215","author":"Yang","year":"2022","journal-title":"Environ. Res."},{"issue":"Pt 1","key":"10.1016\/j.reprotox.2024.108702_bib206","article-title":"Associations between the chemical exposome and pregnancy induced hypertension","volume":"237","author":"Soomro","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.reprotox.2024.108702_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2022.107335","article-title":"Early-pregnancy plasma per- and polyfluoroalkyl substance (PFAS) concentrations and hypertensive disorders of pregnancy in the Project Viva cohort","volume":"165","author":"Preston","year":"2022","journal-title":"Environ. Int."},{"issue":"Pt 1","key":"10.1016\/j.reprotox.2024.108702_bib208","article-title":"Exposure to perfluoroalkyl substances in early pregnancy and the risk of hypertensive disorders of pregnancy: a nested case-control study in Guangxi, China","volume":"288","author":"Liu","year":"2022","journal-title":"Chemosphere"},{"issue":"1","key":"10.1016\/j.reprotox.2024.108702_bib209","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13148-020-00894-6","article-title":"Concentrations of persistent organic pollutants in maternal plasma and epigenome-wide placental DNA methylation","volume":"12","author":"Ouidir","year":"2020","journal-title":"Clin. Epigenet."},{"issue":"Pt 1","key":"10.1016\/j.reprotox.2024.108702_bib210","article-title":"Gestational exposure to perfluoroalkyl substances is associated with placental DNA methylation and birth size","volume":"858","author":"Wang","year":"2023","journal-title":"Sci. Total Environ."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib211","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/toxsci\/kfab028","article-title":"Organophosphate flame retardants, highly fluorinated chemicals, and biomarkers of placental development and disease during mid-gestation","volume":"181","author":"Varshavsky","year":"2021","journal-title":"Toxicol. Sci."},{"issue":"10","key":"10.1016\/j.reprotox.2024.108702_bib212","doi-asserted-by":"crossref","DOI":"10.1289\/EHP9091","article-title":"Maternal Levels of Perfluoroalkyl Substances (PFAS) during early pregnancy in relation to preeclampsia subtypes and biomarkers of preeclampsia risk","volume":"129","author":"Bommarito","year":"2021","journal-title":"Environ. Health Perspect."},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib213","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/HYPERTENSIONAHA.119.14509","article-title":"Differential DNA methylation in placenta associated with maternal blood pressure during pregnancy","volume":"75","author":"Workalemahu","year":"2020","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib214","first-page":"1072","article-title":"Maternal perfluorooctane sulfonic acid exposure during rat pregnancy causes hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in the uterine arteries \u2020","volume":"107","author":"Dangudubiyyam","year":"2022","journal-title":"Biol. Reprod."},{"issue":"18","key":"10.1016\/j.reprotox.2024.108702_bib215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814180","article-title":"Restoring angiotensin Type 2 receptor function reverses PFOS-induced vascular hyper-reactivity and hypertension in pregnancy","volume":"24","author":"Dangudubiyyam","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.reprotox.2024.108702_bib216","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.reprotox.2020.09.008","article-title":"Perfluorooctane sulfonic acid (PFOS) exposure during pregnancy increases blood pressure and impairs vascular relaxation mechanisms in the adult offspring","volume":"98","author":"Dangudubiyyam","year":"2020","journal-title":"Reprod. Toxicol."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib217","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/toxsci\/kft248","article-title":"Elevated blood pressure in offspring of rats exposed to diverse chemicals during pregnancy","volume":"137","author":"Rogers","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"Pt 4)","key":"10.1016\/j.reprotox.2024.108702_bib218","article-title":"Evaluating maternal exposure to an environmental per and polyfluoroalkyl substances (PFAS) mixture during pregnancy: adverse maternal and fetoplacental effects in a New Zealand White (NZW) rabbit model","volume":"838","author":"Crute","year":"2022","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.reprotox.2024.108702_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2023.108390","article-title":"Perfluorooctane sulfonic acid modulates expression of placental steroidogenesis-associated genes and hormone levels in pregnant rats","volume":"118","author":"Dangudubiyyam","year":"2023","journal-title":"Reprod. Toxicol."},{"issue":"11","key":"10.1016\/j.reprotox.2024.108702_bib220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119376","article-title":"Aldosterone biosynthesis is potently stimulated by perfluoroalkyl acids: a link between common environmental pollutants and arterial hypertension","volume":"24","author":"Caroccia","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.reprotox.2024.108702_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2023.109292","article-title":"Endocrine disruptors and arterial hypertension: a developing story","volume":"199","author":"Caroccia","year":"2023","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib222","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/toxsci\/kfaa043","article-title":"Per- and polyfluoroalkyl substances differentially inhibit placental trophoblast migration and invasion in vitro","volume":"175","author":"Szilagyi","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.reprotox.2024.108702_bib223","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2021.117137","article-title":"Nitric oxide mediates disruption of human placental trophoblast invasion induced by perfluorobutane sulfonate","volume":"283","author":"Du","year":"2021","journal-title":"Environ. Pollut."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib224","doi-asserted-by":"crossref","first-page":"79","DOI":"10.26502\/jesph.96120189","article-title":"Whole-genome transcriptome profiling in PFOS-treated uterine artery endothelial cells isolated from pregnant women","volume":"7","author":"Mishra","year":"2023","journal-title":"J. Environ. Sci. Public Health"},{"key":"10.1016\/j.reprotox.2024.108702_bib225","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2022.881347","article-title":"A high-throughput toxicity screen of 42 Per- and Polyfluoroalkyl Substances (PFAS) and functional assessment of migration and gene expression in human placental trophoblast cells","volume":"4","author":"Blake","year":"2022","journal-title":"Front. Toxicol."},{"issue":"12","key":"10.1016\/j.reprotox.2024.108702_bib226","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/tox.23004","article-title":"An assessment of serum-dependent impacts on intracellular accumulation and genomic response of per- and polyfluoroalkyl substances in a placental trophoblast model","volume":"35","author":"Bangma","year":"2020","journal-title":"Environ. Toxicol."},{"issue":"5","key":"10.1016\/j.reprotox.2024.108702_bib227","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.placenta.2015.02.008","article-title":"Reduction of progesterone, estradiol and hCG secretion by perfluorooctane sulfonate via induction of apoptosis in human placental syncytiotrophoblasts","volume":"36","author":"Zhang","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.reprotox.2024.108702_bib228","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fphys.2020.00051","article-title":"Gestational perfluorooctanoic acid exposure inhibits placental development by dysregulation of labyrinth vessels and uNK cells and apoptosis in mice","volume":"11","author":"Jiang","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.reprotox.2024.108702_bib229","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.169151","article-title":"Adverse effects of gestational exposure to hexafluoropropylene oxide trimer acid (HFPO-TA) homologs on maternal, fetal, and placental health in mice","volume":"912","author":"Zhu","year":"2024","journal-title":"Sci. Total Environ."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/toxsci\/kfad097","article-title":"Perfluorooctanoic acid induces transcriptomic alterations in second trimester human cytotrophoblasts","volume":"196","author":"Chen","year":"2023","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.reprotox.2024.108702_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.151739","article-title":"Using comprehensive lipid profiling to study effects of PFHxS during different stages of early zebrafish development","volume":"808","author":"Xu","year":"2022","journal-title":"Sci. Total Environ."},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib232","doi-asserted-by":"crossref","first-page":"27006","DOI":"10.1289\/EHP6233","article-title":"Evaluation of maternal, embryo, and placental effects in CD-1 mice following gestational exposure to Perfluorooctanoic Acid (PFOA) or hexafluoropropylene oxide dimer acid (HFPO-DA or GenX)","volume":"128","author":"Blake","year":"2020","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.reprotox.2024.108702_bib233","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2023.132536","article-title":"Association of adverse fetal outcomes with placental inflammation after oral gestational exposure to hexafluoropropylene oxide dimer acid (GenX) in Sprague-Dawley rats","volume":"461","author":"Lv","year":"2024","journal-title":"J. Hazard. Mater."},{"issue":"4","key":"10.1016\/j.reprotox.2024.108702_bib234","doi-asserted-by":"crossref","first-page":"164","DOI":"10.26502\/jesph.96120197","article-title":"PFOS impairs mitochondrial biogenesis and dynamics and reduces oxygen consumption in human trophoblasts","volume":"7","author":"Hofmann","year":"2023","journal-title":"J. Environ. Sci. Public Health"},{"key":"10.1016\/j.reprotox.2024.108702_bib235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2022.114256","article-title":"Perfluorooctane sulfonate exposure induces preeclampsia-like syndromes by damaging trophoblast mitochondria in pregnant mice","volume":"247","author":"Zhao","year":"2022","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.reprotox.2024.108702_bib236","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntt.2019.106821","article-title":"ROS-mediated JNK pathway critically contributes to PFOS-triggered apoptosis in SH-SY5Y cells","volume":"75","author":"Sun","year":"2019","journal-title":"Neurotoxicol. Teratol."},{"issue":"11","key":"10.1016\/j.reprotox.2024.108702_bib237","doi-asserted-by":"crossref","first-page":"14182","DOI":"10.1096\/fj.202000716RR","article-title":"Perfluorobutane sulfonate exposure disrupted human placental cytotrophoblast cell proliferation and invasion involving in dysregulating preeclampsia related genes","volume":"34","author":"Marinello","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.reprotox.2024.108702_bib238","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2022.113508","article-title":"Perfluorooctanoic acid exposure increases both proliferation and apoptosis of human placental trophoblast cells mediated by ER stress-induced ROS or UPR pathways","volume":"236","author":"Du","year":"2022","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"10","key":"10.1016\/j.reprotox.2024.108702_bib239","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1021\/acs.chemrestox.9b00198","article-title":"PFOS modulates interactive epigenetic regulation in first-trimester human trophoblast cell line HTR-8\/SVneo","volume":"32","author":"Sonkar","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.reprotox.2024.108702_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2021.118542","article-title":"LncRNA MEG3 alleviates PFOS induced placental cell growth inhibition through its derived miR-770 targeting PTX3","volume":"293","author":"Li","year":"2022","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.reprotox.2024.108702_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113964","article-title":"The mechanism of action of non-coding RNAs in placental disorders","volume":"156","author":"Kannampuzha","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.reprotox.2024.108702_bib242","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/mrd.23147","article-title":"LncRNA MEG3 inhibits trophoblast invasion and trophoblast-mediated VSMC loss in uterine spiral artery remodeling","volume":"86","author":"Tao","year":"2019","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.reprotox.2024.108702_bib243","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.127640","article-title":"PFOS-induced placental cell growth inhibition is partially mediated by lncRNA H19 through interacting with miR-19a and miR-19b","volume":"261","author":"Li","year":"2020","journal-title":"Chemosphere"},{"issue":"3","key":"10.1016\/j.reprotox.2024.108702_bib244","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mrd.1080320303","article-title":"Transcription of the H19 gene in differentiating cytotrophoblasts from human placenta","volume":"32","author":"Rachmilewitz","year":"1992","journal-title":"Mol. Reprod. Dev."},{"issue":"11","key":"10.1016\/j.reprotox.2024.108702_bib245","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1289\/ehp.1103412","article-title":"Environmental impact on vascular development predicted by high-throughput screening","volume":"119","author":"Kleinstreuer","year":"2011","journal-title":"Environ. Health Perspect."},{"issue":"11","key":"10.1016\/j.reprotox.2024.108702_bib246","first-page":"843","article-title":"Prenatal exposure to perfluorooctane sulfonate impairs placental angiogenesis and induces aberrant expression of LncRNA Xist","volume":"31","author":"Chen","year":"2018","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.reprotox.2024.108702_bib247","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.reprotox.2020.10.013","article-title":"Exposure to perfluorobutane sulfonate and perfluorooctanesulfonic acid disrupts the production of angiogenesis factors and stress responses in human placental syncytiotrophoblast","volume":"98","author":"Pham","year":"2020","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2024.108702_bib248","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2021.118543","article-title":"Perfluorooctane sulfonic acid (PFOS) inhibits vessel formation in a human 3D co-culture angiogenesis model (NCFs\/HUVECs)","volume":"293","author":"Forsthuber","year":"2022","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.reprotox.2024.108702_bib249","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2020.124491","article-title":"Developmental toxicity of the novel PFOS alternative OBS in developing zebrafish: an emphasis on cilia disruption","volume":"409","author":"Huang","year":"2021","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.reprotox.2024.108702_bib250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijheh.2020.113566","article-title":"Perfluoroctanoic acid (PFOA) enhances NOTCH-signaling in an angiogenesis model of placental trophoblast cells","volume":"229","author":"Poteser","year":"2020","journal-title":"Int. J. Hyg. Environ. Health"},{"issue":"6","key":"10.1016\/j.reprotox.2024.108702_bib251","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9060677","article-title":"PFOS inhibited normal functional development of placenta cells via","volume":"9","author":"Li","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.reprotox.2024.108702_bib252","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2022.153334","article-title":"Structure-activity relationship analysis of perfluoroalkyl carbonic acids on human and rat placental 3\u03b2-hydroxysteroid dehydrogenase activity","volume":"480","author":"Wang","year":"2022","journal-title":"Toxicology"},{"key":"10.1016\/j.reprotox.2024.108702_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152633","article-title":"Perfluoroheptanoic acid induces Leydig cell hyperplasia but inhibits spermatogenesis in rats after pubertal exposure","volume":"448","author":"Li","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.reprotox.2024.108702_bib254","doi-asserted-by":"crossref","DOI":"10.1016\/j.aquatox.2019.105375","article-title":"Contaminant levels and endocrine disruptive effects in Clarias gariepinus exposed to simulated leachate from a solid waste dumpsite in Calabar, Nigeria","volume":"219","author":"Ibor","year":"2020","journal-title":"Aquat. Toxicol."},{"issue":"10","key":"10.1016\/j.reprotox.2024.108702_bib255","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1507\/endocrj.EJ20-0781","article-title":"Maternal exposure of mice to sodium p-perfluorous nonenoxybenzene sulfonate causes endocrine disruption in both dams and offspring","volume":"68","author":"Wang","year":"2021","journal-title":"Endocr. J."},{"key":"10.1016\/j.reprotox.2024.108702_bib256","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2021.118013","article-title":"Probiotics inhibit the stunted growth defect of perfluorobutanesulfonate via stress and thyroid axes in zebrafish larvae","volume":"290","author":"Sun","year":"2021","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.reprotox.2024.108702_bib257","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2021.112107","article-title":"Interaction between probiotic additive and perfluorobutanesulfonate pollutant on offspring growth and health after parental exposure using zebrafish","volume":"214","author":"Liu","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.reprotox.2024.108702_bib258","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.placenta.2016.01.010","article-title":"In utero perfluorooctane sulfonate exposure causes low body weights of fetal rats: a mechanism study","volume":"39","author":"Li","year":"2016","journal-title":"Placenta"},{"issue":"1-2","key":"10.1016\/j.reprotox.2024.108702_bib259","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mce.2011.01.009","article-title":"Perfluorooctanoic acid-induced inhibition of placental prolactin-family hormone and fetal growth retardation in mice","volume":"337","author":"Suh","year":"2011","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.reprotox.2024.108702_bib260","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.mce.2014.10.026","article-title":"Effects of perfluorooctane sulfuric acid on placental PRL-family hormone production and fetal growth retardation in mice","volume":"401","author":"Lee","year":"2015","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.reprotox.2024.108702_bib261","article-title":"Thyroid disrupting effects of old and new generation PFAS","volume":"11","author":"Coperchini","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.reprotox.2024.108702_bib262","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2023.137748","article-title":"Contact to perfluoroalkyl substances and thyroid health effects: a meta-analysis directing on pregnancy","volume":"315","author":"Zhang","year":"2023","journal-title":"Chemosphere"},{"issue":"2","key":"10.1016\/j.reprotox.2024.108702_bib263","doi-asserted-by":"crossref","DOI":"10.3390\/toxics8020043","article-title":"Per- and Polyfluoroalkyl substances in early pregnancy and risk for preeclampsia: a case-control study in Southern Sweden","volume":"8","author":"Rylander","year":"2020","journal-title":"Toxics"},{"issue":"Pt 1","key":"10.1016\/j.reprotox.2024.108702_bib264","article-title":"Gestational hypertension, preeclampsia, and gestational diabetes mellitus after high exposure to perfluoroalkyl substances from drinking water in Ronneby, Sweden","volume":"239","author":"Ebel","year":"2023","journal-title":"Environ. Res."},{"issue":"8","key":"10.1016\/j.reprotox.2024.108702_bib265","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1289\/ehp.1104752","article-title":"Relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth records in the mid-Ohio Valley","volume":"120","author":"Savitz","year":"2012","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.reprotox.2024.108702_bib266","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106442","article-title":"Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the Odense Child Cohort","volume":"151","author":"Birukov","year":"2021","journal-title":"Environ. Int."},{"key":"10.1016\/j.reprotox.2024.108702_bib267","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105656","article-title":"Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: a prospective cohort study","volume":"138","author":"Huo","year":"2020","journal-title":"Environ. Int."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623824001692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623824001692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T02:48:23Z","timestamp":1733366903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623824001692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":267,"alternative-id":["S0890623824001692"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2024.108702","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Per- and polyfluoroalkyl substances (PFAS) and hypertensive disorders of Pregnancy- integration of epidemiological and mechanistic evidence","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2024.108702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108702"}}